Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Shattock

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Scientific Reports|July 26, 2024
Intervention effect of targeted workplace closures may be approximated by single-layered networks in an individual-based model of COVID-19 controlMaximilian Richter, Melissa A Penny, Andrew J Shattock
The International Journal on Drug Policy|March 3, 2015
The cost-effectiveness of harm reductionDavid P Wilson, Braedon Donald, Andrew J Shattock, et al.
Eclinicalmedicine|July 15, 2024
Efficacy thresholds and target populations for antiviral COVID-19 treatments to save lives and costs: a modelling studyEpke A Le Rutte, Andrew J Shattock, Inês Marcelino, et al.
Communications Medicine|July 28, 2022
Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burdenEpke A Le Rutte, Andrew J Shattock, Nakul Chitnis, et al.
Infectious Diseases and Therapy|September 12, 2022
COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target GroupsSherrie L Kelly, Epke A Le Rutte, Maximilian Richter, et al.
Plos Neglected Tropical Diseases|April 11, 2015
Control of trachoma in Australia: a model based evaluation of current interventionsAndrew J Shattock, Manoj Gambhir, Hugh R Taylor, et al.
Elife|July 7, 2022
The influence of biological, epidemiological, and treatment factors on the establishment and spread of drug-resistant <i>Plasmodium falciparum</i>Thiery Masserey, Tamsin Lee, Monica Golumbeanu, et al.
Epidemics|December 19, 2021
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in SwitzerlandAndrew J Shattock, Epke A Le Rutte, Robert P Dünner, et al.
Journal of the International AIDS Society|March 2, 2016
In the interests of time: improving HIV allocative efficiency modelling via optimal time-varying allocationsAndrew J Shattock, Cliff C Kerr, Robyn M Stuart, et al.
Plos One|July 22, 2015
Estimating the Cost-Effectiveness of HIV Prevention Programmes in Vietnam, 2006-2010: A Modelling StudyQuang Duy Pham, David P Wilson, Cliff C Kerr, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Scientific Reports|July 26, 2024
Intervention effect of targeted workplace closures may be approximated by single-layered networks in an individual-based model of COVID-19 controlMaximilian Richter, Melissa A Penny, Andrew J Shattock
The International Journal on Drug Policy|March 3, 2015
The cost-effectiveness of harm reductionDavid P Wilson, Braedon Donald, Andrew J Shattock, et al.
Eclinicalmedicine|July 15, 2024
Efficacy thresholds and target populations for antiviral COVID-19 treatments to save lives and costs: a modelling studyEpke A Le Rutte, Andrew J Shattock, Inês Marcelino, et al.
Communications Medicine|July 28, 2022
Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burdenEpke A Le Rutte, Andrew J Shattock, Nakul Chitnis, et al.
Infectious Diseases and Therapy|September 12, 2022
COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target GroupsSherrie L Kelly, Epke A Le Rutte, Maximilian Richter, et al.
Plos Neglected Tropical Diseases|April 11, 2015
Control of trachoma in Australia: a model based evaluation of current interventionsAndrew J Shattock, Manoj Gambhir, Hugh R Taylor, et al.
Elife|July 7, 2022
The influence of biological, epidemiological, and treatment factors on the establishment and spread of drug-resistant <i>Plasmodium falciparum</i>Thiery Masserey, Tamsin Lee, Monica Golumbeanu, et al.
Epidemics|December 19, 2021
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in SwitzerlandAndrew J Shattock, Epke A Le Rutte, Robert P Dünner, et al.
Journal of the International AIDS Society|March 2, 2016
In the interests of time: improving HIV allocative efficiency modelling via optimal time-varying allocationsAndrew J Shattock, Cliff C Kerr, Robyn M Stuart, et al.
Plos One|July 22, 2015
Estimating the Cost-Effectiveness of HIV Prevention Programmes in Vietnam, 2006-2010: A Modelling StudyQuang Duy Pham, David P Wilson, Cliff C Kerr, et al.
Pageof 2